PCRX - Pacira Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue286,630276,371248,997
Cost of Revenue87,915110,10471,837
Gross Profit198,715166,267177,160
Operating Expenses
Research Development57,29045,67828,662
Selling General and Administrative166,362152,613139,043
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-24,937-32,0249,455
Income from Continuing Operations
Total Other Income/Expenses Net5131,241390
Earnings Before Interest and Taxes-24,424-30,7839,845
Interest Expense18,0477,0617,725
Income Before Tax-42,471-37,8442,120
Income Tax Expense140105264
Minority Interest---
Net Income From Continuing Ops-46,343-37,9491,804
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-42,611-37,9491,856
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-42,611-37,9491,856